Laureen A. Lammers

797 total citations
19 papers, 465 citations indexed

About

Laureen A. Lammers is a scholar working on Pharmacology, Oncology and Physiology. According to data from OpenAlex, Laureen A. Lammers has authored 19 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Laureen A. Lammers's work include Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (6 papers) and Diet and metabolism studies (6 papers). Laureen A. Lammers is often cited by papers focused on Pharmacogenetics and Drug Metabolism (14 papers), Drug Transport and Resistance Mechanisms (6 papers) and Diet and metabolism studies (6 papers). Laureen A. Lammers collaborates with scholars based in Netherlands and Germany. Laureen A. Lammers's co-authors include Ilan J.N. Koppen, Marc A. Benninga, Merit M. Tabbers, Johannes A. Romijn, Ron A. A. Mathôt, Ron H. N. van Schaik, Arnold G. Vulto, Teun van Gelder, Monique J. Bijl and Albert Hofman and has published in prestigious journals such as PLoS ONE, British Journal of Cancer and Psychopharmacology.

In The Last Decade

Laureen A. Lammers

19 papers receiving 443 citations

Peers

Countries citing papers authored by Laureen A. Lammers

Since Specialization

Citations

This map shows the geographic impact of Laureen A. Lammers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laureen A. Lammers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laureen A. Lammers more than expected).

Fields of papers citing papers by Laureen A. Lammers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laureen A. Lammers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laureen A. Lammers. The network helps show where Laureen A. Lammers may publish in the future.

Co-authorship network of co-authors of Laureen A. Lammers

This figure shows the co-authorship network connecting the top 25 collaborators of Laureen A. Lammers. A scholar is included among the top collaborators of Laureen A. Lammers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laureen A. Lammers. Laureen A. Lammers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Impaired liver function: effect on paclitaxel toxicity, dose modifications and overall survival 2024 ·BMC Cancer ·(unknown), Robin W.M. Vernooij, Merel van Nuland, (unknown), Lot A. Devriese, Nadia Haj Mohammad, (unknown), J Stammers, (unknown), Toine C. G. Egberts, Saskia Haitjema, Laureen A. Lammers	2
2	Differential effects of a 40-hour fast and bile acid supplementation on human GLP-1 and FGF19 responses 2019 ·American Journal of Physiology-Endocrinology and Metabolism ·F. Samuel van Nierop, (unknown), (unknown), (unknown), Laureen A. Lammers, Frédéric M. Vaz, Ron A. A. Mathôt, Heinz‐Josef Klümpen, Steven W.M. Olde Damink, Frank G. Schaap, Johannes A. Romijn, E. Marleen Kemper, Maarten R. Soeters	14
3	The effects of fasting on drug metabolism 2019 ·Expert Opinion on Drug Metabolism & Toxicology ·Laureen A. Lammers, (unknown), Ron A. A. Mathôt, Johannes A. Romijn	19
4	Effects of nutritional status on acetaminophen measurement and exposure 2018 ·Clinical Toxicology ·(unknown), Laureen A. Lammers, (unknown), Heinz‐Josef Klümpen, Ron A. A. Mathôt, Johannes A. Romijn	10
5	Nutritional Status Differentially Alters Cytochrome P450 3A4 (CYP3A4) and Uridine 5′-Diphospho-Glucuronosyltransferase (UGT) Mediated Drug Metabolism: Effect of Short-Term Fasting and High Fat Diet on Midazolam Metabolism 2018 ·European Journal of Drug Metabolism and Pharmacokinetics ·Laureen A. Lammers, (unknown), Johannes A. Romijn, Ron A. A. Mathôt	10
6	Nutritional conditioning: The effect of fasting on drug metabolism 2018 ·UvA-DARE (University of Amsterdam) ·Laureen A. Lammers	3
7	Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach 2017 ·Clinical Pharmacokinetics ·Laureen A. Lammers, (unknown), Ron H. N. van Schaik, Johannes A. Romijn, Ron A. A. Mathôt	20
8	Metabolic acidosis caused by concomitant use of paracetamol (acetaminophen) and flucloxacillin? A case report and a retrospective study 2017 ·European Journal of Clinical Pharmacology ·(unknown), Laureen A. Lammers, C. T. Paul Krediet, (unknown), E. Marleen Kemper	12
9	Short-Term Fasting Alters Pharmacokinetics of Cytochrome P450 Probe Drugs: Does Protein Binding Play a Role? 2017 ·European Journal of Drug Metabolism and Pharmacokinetics ·Laureen A. Lammers, (unknown), Johannes A. Romijn, Ron A. A. Mathôt	5
10	Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR 2016 ·PLoS ONE ·Emmely M. de Vries, Laureen A. Lammers, (unknown), (unknown), Ron A. A. Mathôt, Anita Boelen, Johannes A. Romijn	15
11	Quantitative Method for Simultaneous Analysis of a 5-Probe Cocktail for Cytochrome P450 Enzymes 2016 ·Therapeutic Drug Monitoring ·Laureen A. Lammers, (unknown), (unknown), Yuma A. Bijleveld, Emmely M. de Vries, Anita Boelen, Heinz‐Josef Klümpen, Johannes A. Romijn, Ron A. A. Mathôt	11
12	A short-term high fat diet increases exposure to midazolam and omeprazole in healthy subjects 2016 ·Expert Opinion on Drug Metabolism & Toxicology ·(unknown), Laureen A. Lammers, F. Samuel van Nierop, Heinz‐Josef Klümpen, Maarten R. Soeters, Ron A. A. Mathôt, Johannes A. Romijn	10
13	Quantitative Method for Simultaneous Analysis of Acetaminophen and 6 Metabolites 2016 ·Therapeutic Drug Monitoring ·Laureen A. Lammers, (unknown), (unknown), Johannes A. Romijn, Ron A. A. Mathôt	4
14	Management of Functional Constipation in Children: Therapy in Practice 2015 ·Pediatric Drugs ·Ilan J.N. Koppen, Laureen A. Lammers, Marc A. Benninga, Merit M. Tabbers	100
15	Short-Term Fasting Alters Cytochrome P450–Mediated Drug Metabolism in Humans 2015 ·Drug Metabolism and Disposition ·Laureen A. Lammers, (unknown), Emmely M. de Vries, F. Samuel van Nierop, Heinz‐Josef Klümpen, Maarten R. Soeters, Anita Boelen, Johannes A. Romijn, Ron A. A. Mathôt	25
16	Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients 2015 ·Psychopharmacology ·(unknown), (unknown), Kora de Bruin, Anna E. Goudriaan, Laureen A. Lammers, Maarten W.J. Koeter, Wim van den Brink, Jan Booij	32
17	The impact of CYP2D6-predicted phenotype on tamoxifen treatment outcome in patients with metastatic breast cancer 2010 ·British Journal of Cancer ·Laureen A. Lammers, Ron H.J. Mathijssen, Teun van Gelder, Monique J. Bijl, (unknown), Caroline Seynaeve, (unknown), E. Berns, Arnold G. Vulto, Ron H. N. van Schaik	48
18	The CYP2D64 polymorphism affects breast cancer survival in tamoxifen users 2009 ·Breast Cancer Research and Treatment* ·Monique J. Bijl, Ron H. N. van Schaik, Laureen A. Lammers, Albert Hofman, Arnold G. Vulto, Teun van Gelder, Bruno H. Stricker, Loes E. Visser	103
19	Time-dependent Drug-Drug Interaction Alerts in Care Provider Order Entry: Software May Inhibit Medication Error Reductions 2009 ·Journal of the American Medical Informatics Association ·(unknown), Laureen A. Lammers, (unknown), J. Aarts, Marc Berg, Arnold G. Vulto, Teun van Gelder	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact